These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 475360)

  • 41. Effect of disodium phosphonoacetate and iododeoxyuridine on the multiplication of African swine fever virus in vitro.
    Gil-Fernández C; Páez E; Vilas P; Gancedo AG
    Chemotherapy; 1979; 25(3):162-9. PubMed ID: 378573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphonoacetic acid-resistant mutants of herpes simplex virus: effect of phosphonoacetic acid on virus replication and in vitro deoxyribonucleic acid synthesis in isolated nuclei.
    Becker Y; Asher Y; Cohen Y; Weinberg-Zahlering E; Shlomai J
    Antimicrob Agents Chemother; 1977 May; 11(5):919-22. PubMed ID: 195514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversion of mutations in the thymidine kinase gene in herpes simplex viruses resistant to phosphonoacetate.
    Campione-Piccardo J; Rawls WE
    Can J Microbiol; 1984 May; 30(5):560-4. PubMed ID: 6331620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic analysis of the susceptibility of mouse cytomegalovirus to acyclovir.
    Sandford GR; Wingard JR; Simons JW; Staal SP; Saral R; Burns WH
    J Virol; 1985 Apr; 54(1):104-13. PubMed ID: 2983107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.
    Knopf KW; Kaufman ER; Crumpacker C
    J Virol; 1981 Sep; 39(3):746-57. PubMed ID: 6270349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selection for temperature-sensitive mutations in specific vaccinia virus genes: isolation and characterization of a virus mutant which encodes a phosphonoacetic acid-resistant, temperature-sensitive DNA polymerase.
    Sridhar P; Condit RC
    Virology; 1983 Jul; 128(2):444-57. PubMed ID: 6612992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phosphonoformate and phosphonoacetate derivatives of 5-substituted 2'-deoxyuridines: synthesis and antiviral activity.
    Griengl H; Hayden W; Penn G; De Clercq E; Rosenwirth B
    J Med Chem; 1988 Sep; 31(9):1831-9. PubMed ID: 2842506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of action of foscarnet against viral polymerases.
    Crumpacker CS
    Am J Med; 1992 Feb; 92(2A):3S-7S. PubMed ID: 1371038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of the replication of herpes viruses by phosphonoacetate and related compounds.
    Newton AA
    Adv Ophthalmol; 1979; 38():267-75. PubMed ID: 230719
    [No Abstract]   [Full Text] [Related]  

  • 51. Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.
    Schnipper LE; Crumpacker CS
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2270-3. PubMed ID: 6246532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.
    Alenius S; Dinter Z; Oberg B
    Antimicrob Agents Chemother; 1978 Sep; 14(3):408-13. PubMed ID: 213015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine.
    Nasisse MP; Guy JS; Davidson MG; Sussman W; De Clercq E
    Am J Vet Res; 1989 Jan; 50(1):158-60. PubMed ID: 2493210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced survival of ultraviolet-irradiated herpes simplex virus in cells exposed to antiviral agents.
    Schnipper LE; Lewin AA; Crumpacker CS
    Mutat Res; 1983 Feb; 116(2):65-72. PubMed ID: 6298618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of cytomegalovirus late antigens by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 12(6):335-9. PubMed ID: 6244238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1980; 66(3):261-4. PubMed ID: 6449917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
    Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
    Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1989; 40(2):213-85. PubMed ID: 2543994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trisodium phosphonoformate inhibits woodchuck hepatitis virus associated DNA polymerase.
    Nordenfelt E; Werner B
    Acta Pathol Microbiol Scand B; 1980 Jun; 88(3):183-4. PubMed ID: 6449828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.